Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christine A. Ciunci"'
Autor:
Jeffrey C. Thompson, MD, MTR, Charu Aggarwal, MD, MPH, Janeline Wong, BS, Vivek Nimgaonkar, BS, Wei-Ting Hwang, PhD, Michelle Andronov, BS, David M. Dibardino, MD, Christoph T. Hutchinson, MD, MA, Kevin C. Ma, MD, Anthony Lanfranco, MD, MS, Edmund Moon, MD, Andrew R. Haas, MD, PhD, Aditi P. Singh, MD, Christine A. Ciunci, MD, MSCE, Melina Marmarelis, MD, MSCE, Christopher D’Avella, MD, Justine V. Cohen, DO, Joshua M. Bauml, MD, Roger B. Cohen, MD, Corey J. Langer, MD, Anil Vachani, MD, MSCE, Erica L. Carpenter, MBA, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 4, Pp 100301- (2022)
Introduction: The availability of targeted therapies has transformed the management of advanced NSCLC; however, most patients do not undergo guideline-recommended tumor genotyping. The impact of plasma-based next-generation sequencing (NGS) performed
Externí odkaz:
https://doaj.org/article/1e4a79ab12aa4b34955ec3972d774b0c
Autor:
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, Michelle Iocolano, Kristine N. Kim, Abigail Doucette, Roger B. Cohen, Kyle W. Robinson, William P. Levin, Keith A. Cengel, Brian Lally, Manuj Agarwal, Christopher A. D'Avella, Melina E. Marmarelis, John A. Kosteva, Aditi P. Singh, Christine A. Ciunci, Charu Aggarwal, Abigail T. Berman, Corey J. Langer, Steven J. Feigenberg
Publikováno v:
Clinical Lung Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1133f70dfe1adf0086801ef683360e8
https://doi.org/10.1016/j.cllc.2023.03.013
https://doi.org/10.1016/j.cllc.2023.03.013
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Mutations Analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08350c21e7795ce9c29cff93a63f6bbf
https://doi.org/10.1158/1078-0432.22475610
https://doi.org/10.1158/1078-0432.22475610
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Purpose:The role of plasma-based tumor mutation burden (pTMB) in predicting response to pembrolizumab-based first-line standard-of-care therapy for metastatic non–small cell lung cancer (mNSCLC) has not been explored.Experimental Design:A 500-gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dfee398bbbbfc5c85644bb8ae085830
https://doi.org/10.1158/1078-0432.c.6529125
https://doi.org/10.1158/1078-0432.c.6529125
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
pTMBand PD-L1 expression levels.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907404d8eb997d205afbd17afc601de9
https://doi.org/10.1158/1078-0432.22475613.v1
https://doi.org/10.1158/1078-0432.22475613.v1
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Development and validation of a plasma-based panel for mutation detection and assessment of TMB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab8830cf164cccd5b1739f881aa15920
https://doi.org/10.1158/1078-0432.22475619.v1
https://doi.org/10.1158/1078-0432.22475619.v1
Autor:
Melina E. Marmarelis, Xiao Wang, Leonid Roshkovan, Connor B. Grady, John T. Miura, Michelle S. Ginsberg, Christine A. Ciunci, Jacklynn Egger, Suzanne Walker, Andrea Cercek, Michael B. Foote, Leslie A. Litzky, Garrett Nash, Andrew R. Haas, Giorgos C. Karakousis, Keith A. Cengel, Sharyn I. Katz, Marjorie G. Zauderer, Corey J. Langer, Michael Offin
Publikováno v:
JAMA Network Open. 6:e232526
ImportanceDiffuse malignant peritoneal mesothelioma (DMPM) represents a rare and clinically distinct entity among malignant mesotheliomas. Pembrolizumab has activity in diffuse pleural mesothelioma but limited data are available for DMPM; thus, DMPM-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::224980a0b8ee68b58d233eac8e2abad8
https://doi.org/10.1001/jamanetworkopen.2023.2526
https://doi.org/10.1001/jamanetworkopen.2023.2526
Autor:
Xiuning Le, Lingzhi Hong, Chuck Hensel, Rongrong Chen, Haley Kemp, Niamh Coleman, Christine A. Ciunci, Stephen V. Liu, Marcelo V. Negrao, Jennifer Yen, Xuefeng Xia, Juergen Scheuenpflug, Christopher Stroh, Dilafruz Juraeva, Anne Tsao, David Hong, Victoria Raymond, Paul Paik, Jianjun Zhang, John V. Heymach
Publikováno v:
JCO Precision Oncology
PURPOSE MET exon 14 skipping alterations ( METex14) comprise a diverse set of actionable oncogene drivers in non–small-cell lung cancer (NSCLC). Recent studies have established the efficacy of tyrosine kinase inhibitors for this patient population.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87609a619f3a38da1b197d1058e012ce
http://europepmc.org/articles/PMC8694524
http://europepmc.org/articles/PMC8694524
Autor:
Xiao Wang, Michael Offin, Leonid Roshkovan, John Miura, Michelle S. Ginsberg, Christine Agnes Ciunci, Jacklynn V. Egger, Suzanne Walker, Andrea Cercek, Leslie Litzky, Garrett Michael Nash, Andrew Haas, Giorgos Karakousis, Keith A. Cengel, Sharyn I. Katz, Marjorie Glass Zauderer, Corey J. Langer, Melina Elpi Marmarelis
Publikováno v:
Journal of Clinical Oncology. 40:8557-8557
8557 Background: Among patients with malignant mesothelioma, pembrolizumab has demonstrated activity in diffuse pleural mesothelioma (DPM), with limited data available for those with diffuse malignant peritoneal mesothelioma (DMPM). DMPM represents a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31c695a1930e576c52e3d8b3ea10fd14
https://doi.org/10.1200/jco.2022.40.16_suppl.8557
https://doi.org/10.1200/jco.2022.40.16_suppl.8557
Autor:
Christine M. Veenstra, Christine Agnes Ciunci, Andrew J. Epstein, Anil Vachani, E. Carter Paulson
Publikováno v:
Cancer. 121:3525-3533
BACKGROUND Little is known about recent trends in surveillance among the more than 1 million US colorectal cancer (CRC) survivors. Moreover, for stage I disease, which accounts for more than 30% of survivors, the guidelines are limited, and the use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::532cbf56446431056f2ca258b70489a0
https://doi.org/10.1002/cncr.29469
https://doi.org/10.1002/cncr.29469